Absence of SOX11 over-expression in lymphoid progenitor or in mature normal B-cells, correlated with IGHV mutational status in MCL, makes SOX11 a potential biomarker for CCND1-negative MCL, both at diagnosis and in the evaluation of minimal residual disease (MRD). This evidence concerns the gene CCND1 and mantle cell lymphoma.